Fortis owns 27 per cent stake in RHT at the moment. Bulk of the current fund infusion will go into the buyback of healthcare assets that are currently leased out from the RHT.

Recent cases indicate that Indian courts are taking an increasingly pro-arbitration stance by refusing to interfere in arbitral awards on merits.

The Delhi High Court on Thursday directed former Ranbaxy Laboratories Ltd promoter Shivinder Singh to pay the money owed to Japanese pharma major Daiichi Sankyo under an arbitral award won by it in 2016.

Daiichi Sankyo, which has filed an intervention application in the insolvency plea filed by HDFC Bank, said they have a decree to recover money against RHC Holding.

Shivinder Singh says he decided to withdraw the case after \"repeated urging\" by his mother. He also says his decision to disassociate from his brother, and tread an independent path, stands.

Cars and other durables to get costlier this festive seasonWith the rupee's continuous fall against the dollar automobile and consumer goods companies are facing a tough time. This festive season will see these goods become more expensive. LG, Haier, and Godrej Appliances have hiked prices by 3-5 per cent this month. Panasonic India is expected to increase product prices by 2-3 per cent soon as reported by the Business Standard. Maruti Suzuki, the country's largest carmaker, has i...

In his petition before the National Company Law Tribunal in New Delhi, Shivinder has leveled the following charges against elder brother Malvinder and former Religare CEO Sunil Godhwani.

Shivinder Singh reveals he has split with his brother Malvinder Singh to follow his \"own path\"; holds Malvinder and Godhwani responsible for systematic undermining of the interests of their companies and their shareholders.

Nearly Rs 2,700 crore of Ranbaxy sale proceeds were transferred to firms owned by the Dhillon family and associates and senior functionaries of the RSSB sect.

How Malvinder and Shivinder Singh blew Rs 22,500 crore in less than a decade and lost control over Fortis Healthcare and Religare Enterprises.

The Delhi High Court has also asked the former promoters of Fortis Healthcare Limited, popularly known as the Singh brothers, to disclose all their transactions, including gifts, since 2016.

The Delhi High Court yesterday directed the erstwhile promoters of Fortis Healthcare (FHL), the Singh brothers, to appear in person for the next hearing of case filed by Daiichi Sankyo.

Ever since Bhavdeep Singh was roped in as CEO by the country's second-largest hospital chain, its losses rose from Rs 73.6 crore in 2015-16 to Rs 74.7 crore in 2016-17.

Malvinder and his brother Shivinder Singh had resigned as directors from FHL's board in February this year, following the Delhi High Court order upholding the Rs 3,500 crore arbitral award in favour of Daiichi Sankyo.

The development has cast a shadow over the ongoing attempt to sell Fortis as these four directors were among the five who had voted in favour of Munjals-Burmans' Rs 1,800 crore bid for the healthcare firm.

Fortis Healthcare today said its shareholders have voted in favour of removal of Brian Tempest from the Board of Directors in the company's extraordinary general meeting (EGM) held on May 22.

Fortis' largest shareholder, Yes Bank, has asked the board to consider all the bids (binding as well as non-binding) despite the board recommending the Munjal-Burman offer.

After Munjal-Burman bid was announced as the preferred bid by the Fortis Healthcare board, Sunil Kant Munjal and Anand Burman spoke to BusinessToday.In Editor Rajeev Dubey and Business Today, Senior Editor Joe C Mathew about being minority shareholders, investing in Fortis and whether it is an equal investment.